Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

We have observed 19 EP applications Michaela Klaus has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14707126

ANTI-MCSP ANTIBODIES

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/30
Applicant:
Roche Glycart AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14745049

ELUCIDATION OF ION EXCHANGE CHROMATOGRAPHY INPUT OPTIMIZATION

IPC classification:
B01D 15/08, B01D 15/36, C07K 1/16, C07K 1/18, G01N 30/86
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Genentech, Inc.
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14841863

METHOD FOR CHROMATOGRAPHY REUSE

IPC classification:
B01D 15/08
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14844125

BIOREACTORS WITH MULTIPLE OR ADJUSTABLE -POSITION AGITATOR DESIGNS

IPC classification:
B01D 15/22, B01F 7/00, B01F 15/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
BOHEST AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14862284

METHODS FOR VIRAL INACTIVATION USING ECO-FRIENDLY DETERGENTS

IPC classification:
A61K 38/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15703392

H7N9 INFLUENZA A THERAPIES WITH ANTI-H7 VIRUS ANTIBODIES

IPC classification:
A61K 31/215, A61K 39/395, A61P 31/16, C07K 16/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15716209

METHODS AND COMPOSITIONS FOR SECRETION OF HETEROLOGOUS POLYPEPTIDES

IPC classification:
C07K 16/00, C12N 15/13, C12N 15/62, C12N 15/70, C12P 21/02
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15715932

METHODS OF PREPARING A POLOXAMER FOR USE IN CELL CULTURE MEDIUM

IPC classification:
C08G 65/30, C12N 5/00
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Genentech, Inc.
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15716285

ANTI-INFLUENZA B VIRUS HEMAGGLUTININ ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/00, C07K 16/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15739141

POLYPEPTIDE EXPRESSION SYSTEMS

IPC classification:
C07K 16/00, C12N 15/10, C12N 15/62, C12N 15/85, G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15750845

PH ADJUSTMENT TO IMPROVE THAW RECOVERY OF CELL BANKS

IPC classification:
A01N 1/02, C12N 5/07
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15766949

APPARATUS AND METHODS FOR SEALING A MEDICAMENT WITHIN A MEDICAL DELIVERY DEVICE

IPC classification:
A61M 39/20, B65D 51/24, F26B 5/06
Applicant:
F. Hoffmann-La Roche AG
Agent:
BOHEST AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15772084

IMMUNOGENIC MUTANT PEPTIDE SCREENING PLATFORM

IPC classification:
A61K 39/00, C12Q 1/68, G01N 33/569, G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15802233

METHODS OF PRODUCING TWO CHAIN PROTEINS IN BACTERIA

IPC classification:
C07K 16/00, C07K 16/24, C07K 16/46
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15797767

ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF

IPC classification:
C07K 16/24
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15802254

THERAPEUTIC AND DIAGNOSTIC METHODS FOR IL-33-MEDIATED DISORDERS

IPC classification:
C12Q 1/68, G01N 33/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15816304

ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF

IPC classification:
A61K 47/50
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15823166

A NOVEL HIGH-THROUGHPUT METHOD FOR QUANTIFICATION OF HBV CCCDNA FROM CELL LYSATE BY REAL-TIME PCR

IPC classification:
C12Q 1/70
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16703446

RECOMBINANT HBV CCCDNA, THE METHOD TO GENERATE THEREOF AND THE USE THEREOF

IPC classification:
A61K 49/00, C12N 7/00, C12N 15/70, G01N 33/50, G01N 33/576
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michaela Klaus, F. Hoffmann-La Roche AG
Status:
Request for examination was made

Please Sign in to use this feature